Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in ulcerative colitis
NCT01393405Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2012
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in ulcerative colitis (UC), sponsored by University of North Carolina at Chapel Hill. Started Feb 2012; status: completed.
02
Drugs
methotrexate
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01393405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393405.